| Address: | 9806 Sunset Ave, La Mesa, CA 91941, USA |
|---|---|
| Postal code: | 91941 |
| Phone: | (619) 466-4220 |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Entest Biomedical, use the form below and your opinion, advice or comment will appear in this space.
Entest Biomedical at 9806 Sunset Ave in La Mesa, CA. Read about, contact, get directions and find other Consultants - General. Entest Biomedical. (619) 466-4220.
Entest Biomedical, Inc Entest Biomedical, Inc. 0 customer reviews - add your review. 8885 Rehco Road San Diego, CA 92121 Phone: (619) 466-4220.
Entest Biomedical. Find business information, reviews, maps, coupons, driving directions and more. Entest Biomedical. 9806 Sunset Ave La Mesa, CA 91941. (619) 466-4220.
Entest Biomedical offers Medical Laboratories services in the San Diego, CA area. For more info call (619) 466-4220!
Learn about working at Entest BioMedical. Join LinkedIn today for free. See more information about Entest BioMedical, find and apply to jobs that match your skills, and connect with people to advance your career.
5. Entest Biomedical.
"Entest Biomedical" of La Mesa, CA 91941 operates primarily in SIC Code 8071 - Medical Laboratories and NAICS Code 621511 - Medical Laboratories. Entest Biomedical is a medium-sized business with medium revenue, that is established in its industry.
Entest BioMedical, Inc. engages in the development and commercialization of immunotherapeutic therapies for the veterinary market. The company is developing ImenVax family of canine cancer vaccines, which include ImenVax I, a therapeutic for canine cancer, which is involved in isolating...
ENTEST BIOMEDICAL INC. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | OTC Bulletin Board Company contact information. Entest Group, Inc. 4700 Spring Street Suite 304 La Mesa, CA 91942. Phone : +1.619.702.1404.
Entest BioMedical's (OTCPINK: ENTB) wholly owned subsidiary Zander Therapeutics, Inc. announced the filing of a patent application covering composition of matter and methods of use related to molecules identified in their small molecule program that activate and inhibit NR2F6...